Actinium Pharmaceuticals
ATNM
ATNM
69 hedge funds and large institutions have $10.2M invested in Actinium Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
36% less capital invested
Capital invested by funds: $15.9M → $10.2M (-$5.65M)
Holders
69
Holding in Top 10
–
Calls
$91K
Puts
$6K
Top Buyers
| 1 | +$139K | |
| 2 | +$129K | |
| 3 | +$125K | |
| 4 |
Renaissance Technologies
New York
|
+$79.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$65.3K |
Top Sellers
| 1 | -$432K | |
| 2 | -$405K | |
| 3 | -$314K | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$169K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$147K |